|
[1]
|
Jamieson, C.R., et al. (1994) Mapping a Gene for Noonan Syndrome to the Long Arm of Chromosome 12. Nature Genetics, 8, 357-360. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Chan, R.J. and Feng, G.S. (2007) PTPN11 Is the First Identified Proto-Oncogene that Encodes a Tyrosine Phosphatase. Blood, 109, 862-867. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Östman, A., Hellberg, C. and Böhmer, F.D. (2006) Protein-Tyrosine Phosphatases and Cancer. Nature Reviews Cancer, 6, 307-320. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Grossmann, K.S., Rosário, M., Birchmeier, C., et al. (2010) The Tyrosine Phosphatase Shp2 in Development and Cancer. Advances in Cancer Research, 106, 53-89. [Google Scholar] [CrossRef]
|
|
[5]
|
Tartaglia, M., Mehler, E., Goldberg, R., et al. (2001) Mutations in PTPN11, Encoding the Protein Tyrosine Phosphatase SHP-2, Cause Noonan Syndrome. Nature Genetics, 29, 465-468. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Zhang, J., Zhang, F. and Niu, R. (2015) Functions of Shp2 in Cancer. Journal of Cellular and Molecular Medicine, 19, 2075-2083. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Levy, A.D., Xiao, X., Shaw, J.E., et al. (2018) Noonan Syndrome Associated SHP2 Dephosphorylates GluN2B to Regulate NMDA Receptor Function. Cell Reports, 24, 1523-1535. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Mulero-Navarro, S., Sevilla, A., Roman, A., et al. (2015) Myeloid Dysregulation in a Human Induced Pluripotent Stem Cell Model of PTPN11-Associated Juvenile Myelomonocytic Leukemia. Cell Reports, 13, 504-515. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Bentires-Alj, M., Paez, J.G., David, F.S., et al. (2004) Activating Mutations of the Noonan Syndrome-Associated SHP2/PTPN11 Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia. Cancer Research, 64, 8816-8820. [Google Scholar] [CrossRef]
|
|
[10]
|
朱霞. 含唑基多齿柔性配体配位聚合物的合成、结构和性质研究[D]: [博士学位论文]. 苏州: 苏州大学, 2012.
|
|
[11]
|
Li, B.L., Li, B., Zhang, R.L., et al. (2016) Synthesis and Antiproliferative Evaluation of Novel 1, 2, 4-Triazole Derivatives Incorporating Benzisoselenazolone Scaffold. Bioorganic & Medicinal Chemistry Letters, 26, 1279-1281. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Marwaha, A., White, J., El Mazouni, F., et al. (2012) Bioisosteric Transformations and Permutations in the Triazolopyrimidine Scaffold to Identify the Minimum Pharmacophore Required for Inhibitory Activity against Plasmodium Falciparum Dihydroorotate Dehydrogenase. Journal of Medicinal Chemistry, 55, 7425-7436. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Wittine, K., Stipković Babić, M., Makuc, D., et al. (2012) Novel 1, 2, 4-Triazole and Imidazole Derivatives of L-Ascorbic and Imino-Ascorbic Acid: Synthesis, Anti-HCV and Antitumor Activity Evaluations. Bioorganic & Medicinal Chemistry, 20, 3675-3685. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Liu, N., Tu, J., Dong, G.Q., et al. (2018) Emerging New Targets for the Treatment of Resistant Fungal Infections. Journal of Medical Chemistry, 61, 5484-5511. [Google Scholar] [CrossRef] [PubMed]
|